These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Burden of illness of bilateral neovascular age-related macular degeneration in Spain. Ruiz-Moreno JM; Coco RM; García-Arumí J; Xu X; Zlateva G Curr Med Res Opin; 2008 Jul; 24(7):2103-11. PubMed ID: 18547463 [TBL] [Abstract][Full Text] [Related]
5. The depletion of susceptibles effect in the assessment of burden-of-illness: the example of age-related macular degeneration in the community-dwelling elderly population of Quebec. Tournier M; Moride Y; Lesk M; Ducruet T; Rochon S Can J Clin Pharmacol; 2008; 15(1):e22-35. PubMed ID: 18579928 [TBL] [Abstract][Full Text] [Related]
6. Association between Ranibizumab Injections and Risk of Acute Myocardial Infarction in Age-related Macular Degeneration: A Case-crossover Study. Ryu SY; Kim J; Kim DW; Chung EJ Korean J Ophthalmol; 2020 Apr; 34(2):150-157. PubMed ID: 32233149 [TBL] [Abstract][Full Text] [Related]
7. Prevalence and Incidence of Exudative Age-Related Macular Degeneration in South Korea: A Nationwide Population-Based Study. Park SJ; Kwon KE; Choi NK; Park KH; Woo SJ Ophthalmology; 2015 Oct; 122(10):2063-70.e1. PubMed ID: 26208437 [TBL] [Abstract][Full Text] [Related]
8. The burden of age-related macular degeneration. Schmier JK; Jones ML; Halpern MT Pharmacoeconomics; 2006; 24(4):319-34. PubMed ID: 16605279 [TBL] [Abstract][Full Text] [Related]
9. Burden of illness of neovascular age-related macular degeneration in Canada. Cruess A; Zlateva G; Xu X; Rochon S Can J Ophthalmol; 2007 Dec; 42(6):836-43. PubMed ID: 18026200 [TBL] [Abstract][Full Text] [Related]
11. A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment. Kilian R; Matschinger H; Löeffler W; Roick C; Angermeyer MC J Ment Health Policy Econ; 2002 Mar; 5(1):21-31. PubMed ID: 12529567 [TBL] [Abstract][Full Text] [Related]
12. The burden of age-related macular degeneration: results of a cohort study in two French referral centres. Bonastre J; Le Pen C; Soubrane G; Quentel G Pharmacoeconomics; 2003; 21(3):181-90. PubMed ID: 12558468 [TBL] [Abstract][Full Text] [Related]
13. Treatment Patterns and Health Care Costs for Age-Related Macular Degeneration in Japan: An Analysis of National Insurance Claims Data. Kume A; Ohshiro T; Sakurada Y; Kikushima W; Yoneyama S; Kashiwagi K Ophthalmology; 2016 Jun; 123(6):1263-8. PubMed ID: 26927204 [TBL] [Abstract][Full Text] [Related]
14. Quality of Life in Patients Suffering from Active Exudative Age-Related Macular Degeneration: The EQUADE Study. Matamoros E; Maurel F; Léon N; Solomiac A; Bardoulat I; Joubert M; Hermans M; Moser E; Le Picard S; Souied EH; Leveziel N Ophthalmologica; 2015; 234(3):151-9. PubMed ID: 26337381 [TBL] [Abstract][Full Text] [Related]
15. [Neovascular age-related macular degeneration in Germany. Encroachment on the quality of life and the financial implications]. Pauleikhoff D; Scheider A; Wiedmann P; Gelisken F; Scholl HP; Roider I; Mohr A; Zlateva G; Xu X Ophthalmologe; 2009 Mar; 106(3):242-51. PubMed ID: 18709375 [TBL] [Abstract][Full Text] [Related]
16. Eye-related medicare costs for patients with age-related macular degeneration from 1995 to 1999. Coleman AL; Yu F Ophthalmology; 2008 Jan; 115(1):18-25. PubMed ID: 17572499 [TBL] [Abstract][Full Text] [Related]
17. Treatment Options for Age-Related Macular Degeneration: A Budget Impact Analysis from the Perspective of the Brazilian Public Health System. Elias FT; Silva EN; Belfort R; Silva MT; Atallah ÁN PLoS One; 2015; 10(10):e0139556. PubMed ID: 26457416 [TBL] [Abstract][Full Text] [Related]
18. Role of statins in the development and progression of age-related macular degeneration. VanderBeek BL; Zacks DN; Talwar N; Nan B; Stein JD Retina; 2013 Feb; 33(2):414-22. PubMed ID: 23314233 [TBL] [Abstract][Full Text] [Related]
19. The economic impact of blue-light filtering intraocular lenses on age-related macular degeneration associated with cataract surgery: a third-party payer's perspective. Reddy P; Gao X; Barnes R; Fairchild C; Boci K; Waycaster C; Pashos C Curr Med Res Opin; 2006 Jul; 22(7):1311-8. PubMed ID: 16834830 [TBL] [Abstract][Full Text] [Related]